Metraipolis › archive › dc_a04718ee3a28
Chronic oral cannabidiol delays seizure onset and reduces seizure burden in a mouse model of CLN2 disease — Europe PMC PMID:42475369
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42475369
- DOI
- 10.1371/journal.pone.0337880
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T04:02:19.415Z
- SHA-256 of the archived text
5739ed62bc3c5e0c7824b07bcbcb524f7ec06e0eee39d2f377514b1cec0d6b9f- Stable URL of this page
https://metraipolis.com/documento/dc_a04718ee3a28
How to cite
Chronic oral cannabidiol delays seizure onset and reduces seizure burden in a mouse model of CLN2 disease — Europe PMC PMID:42475369 — Europe PMC (en), https://europepmc.org/article/MED/42475369 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a04718ee3a28 (Metraipolis archive dc_a04718ee3a28, sha256 5739ed62bc3c5e0c7824b07bcbcb524f7ec06e0eee39d2f377514b1cec0d6b9f)
BibTeX
@misc{dca04718ee3a28,
title = {Chronic oral cannabidiol delays seizure onset and reduces seizure burden in a mouse model of CLN2 disease — Europe PMC PMID:42475369},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42475369},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a04718ee3a28; sha256 5739ed62bc3c5e0c7824b07bcbcb524f7ec06e0eee39d2f377514b1cec0d6b9f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42475369. Agents can read the archived copy with the MCP tool read_document.